Ipilimumab 認識標靶藥品Ipilimumab
2026/7/21
Ipilimumab is a monoclonal antibody that binds to CTLA-4 (human cytotoxic T lymphocyte-associated antigen 4) on T cells. By blocking CTLA-4, ipilimumab helps strengthen the immune system by promoting the function and growth of T cells, thereby enhancing the immune system against cancer cells.